Scientific Board

Geoffrey Burgess, MD

Dr. Burgess is currently Chief Medical Officer at Glutalor Medical. Dr. Burgess just retired after 40 years practice as a family medicine specialist with focus on diabetes in west Philadelphia area. Dr. Burgess graduated from Pennsylvania State University College of Medicine in 1975. Dr. Burgess founded Gateway Medical Associates in 1986 and worked as Medical Director at Tandigm Health from 2014 to 2017.

Michael A Friedman, MD

Dr. Friedman is an experienced healthcare leader with a distinguished career in oncology research, regulatory strategy, and public healthcare policy.  He served as President and CEO of City of Hope, a leading cancer research, treatment and education institution, as well as director of the organization’s Comprehensive Cancer Center.  Before that, Dr. Friedman was SVP of R&D, medical and public policy for Pharmacia Corp.  Dr. Friedman previously served as deputy commissioner for the U.S. FDA, later serving as acting commissioner.  Dr. Friedman holds a MD degree from the University of Texas and received his bachelor’s degree from Tulane University. Dr. Friedman currently serves on the board of Mannkind, Cytovia, Sermonix and as a trustee of Tulane University and on the California Stem Cell Oversight Board.  He has served as a nonexecutive director on the boards of Celgene, Smith and Nephew, and Intuitive Surgical.

Larry Kaiser, MD

With more than 20 years of leadership experience in a variety of healthcare institutions, Dr. Kaiser was most recently the President and CEO of the Temple University Health System, a $2.2 billion system, where he led a transformation over the past nine years. He was responsible for the acquisition of the Fox Chase Cancer Center, one of the original NCI-designated comprehensive cancer centers, and spearheaded the development of several nationally recognized programs including the number one lung transplant program in the country. Immediately prior to joining Temple, Dr. Kaiser served as President of the University of Texas Health Science Center at Houston. Prior to that he spent 17-years at the University of Pennsylvania, where he was the John Rhea Barton Professor and Chairman of the Department of Surgery and Surgeon-in-Chief of the Penn Health System. Dr. Kaiser earned a bachelor’s degree in chemistry and a medical degree from Tulane University. He completed a residency in general surgery, in addition to a fellowship in surgical oncology, at the University of California, Los Angeles.